HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Young patient with eyelid Merkel carcinoma: Mohs microsurgery versus exenteration].

AbstractCASE REPORT:
We present the case of a 47-year-old female suffering from progeria who developed an eyelid Merkel cell carcinoma (MCC) following cyclosporine treatment for a corneal transplant. She underwent excision of the lesion by Mohs micrographic surgery (MMS) and received adjuvant treatment with radiotherapy. Later she had a recurrent tumour for which a wide excision with orbital exenteration was performed. The patient was fit and well at the 24-month follow-up.
DISCUSSION:
MCC is an aggressive tumour that has a larger incidence in elderly people, women and immunosuppressed patients. Our approach with the patient must be global, avoiding risk factors in predisposed subjects. MMS seems unsuitable for the treatment of MCC; if tumour recurrence occurs a wide resection should be performed (Arch Soc Esp Oftalmol 2009; 84: 581-584).
AuthorsM A Rodríguez-Prieto, T Alonso-Alonso, J A Toribio-García, A Mateos-Hernández
JournalArchivos de la Sociedad Espanola de Oftalmologia (Arch Soc Esp Oftalmol) Vol. 84 Issue 11 Pg. 581-4 (Nov 2009) ISSN: 1989-7286 [Electronic] Spain
Vernacular TitlePaciente joven con carcinoma de Merkel palpebral: microcirugía de Mohs versus exenteración.
PMID19967613 (Publication Type: Case Reports, English Abstract, Journal Article)
Topics
  • Carcinoma, Merkel Cell (surgery)
  • Eyelid Neoplasms (surgery)
  • Female
  • Humans
  • Middle Aged
  • Mohs Surgery
  • Neoplasms, Second Primary (surgery)
  • Orbit Evisceration
  • Orbital Neoplasms (surgery)
  • Skin Neoplasms (surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: